Premium
Hydroyxurea improves cerebral oxygen saturation in children with sickle cell anemia
Author(s) -
Karkoska Kristine,
Quinn Charles T.,
Niss Omar,
Pfeiffer Amanda,
Dong Min,
Vinks Alexander A.,
McGann Patrick T.
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26120
Subject(s) - medicine , cohort , sickle cell anemia , transcranial doppler , anemia , hypoxia (environmental) , pediatrics , surgery , disease , chemistry , organic chemistry , oxygen
Neurologic complications are common in patients with sickle cell anemia (SCA), but conventional tools such as MRI and transcranial Doppler ultrasonography (TCD) do not fully assess cerebrovascular pathology. Cerebral tissue oximetry measures mixed oxygen saturation in the frontal lobes (S CT O 2 ) and provides early prognostic information about tissue at risk of ischemic injury. Untreated patients with SCA have significantly lower S CT O 2 than healthy controls that declines with age. Hydroxyurea is effective in preventing many SCA‐related complications, but the degree to which it preserves normal neurophysiology is unclear. We analyzed participants enrolled in the Therapeutic Response Evaluation and Adherence Trial (TREAT, NCT02286154), which enrolled participants initiating hydroxyurea using individualized dosing (new cohort) and those previously taking hydroxyurea (old cohort) and was designed to monitor the long‐term benefits of hydroxyurea. Cerebral oximetry was performed at baseline and annually. For the new cohort (median starting age = 12 months, n = 55), mean baseline S CT O 2 was normal before starting hydroxyurea (mean 65%, 95% CI 58–72%) and significantly increased after 2 years (mean 72%, 95% CI 65–79%, p < .001). The S CT O 2 for patients receiving long‐term hydroxyurea (median age = 9.6 years) was normal at study entry (mean 66%, 95% CI 58–74%) and remained stable across 2 years. Both cohorts had significantly higher S CT O 2 than published data from predominantly untreated SCA patients. Cerebral oximetry is a non‐invasive method to assess cerebrovascular pathology that complements conventional imaging. Our results indicate that hydroxyurea suggests protection against neurophysiologic changes seen in untreated SCA.